Your browser doesn't support javascript.
loading
Predicting COVID-19 infection risk in people who are immunocompromised by antibody testing.
Wijaya, Ratna; Johnson, Marina; Campbell, Nicola; Stuart, Beth; Kelly, Adam; Tipler, Nicole; Menne, Tobias; Ahearne, Matthew J; Willimott, Victoria; Al-Naeeb, Anna Bowzyk; Fox, Christopher P; Collins, Graham P; O'Callaghan, Ann; Davies, Andrew J; Goldblatt, David; Lim, Sean H.
Afiliación
  • Wijaya R; Centre for Cancer Immunology, University of Southampton, Southampton SO16 6YD, UK.
  • Johnson M; Great Ormond Street Institute of Child Health Biomedical Research Centre, University College London, London, UK.
  • Campbell N; Centre for Cancer Immunology, University of Southampton, Southampton SO16 6YD, UK.
  • Stuart B; Centre for Evaluation and Methods, Wolfson Institute of Population Health, Faculty of Medicine and Dentistry, Queen Mary University of London, London, UK.
  • Kelly A; Centre for Cancer Immunology, University of Southampton, Southampton SO16 6YD, UK; National Institute for Health Research and Cancer Research UK Southampton Experimental Cancer Medicine Centre, Wessex Investigational Sciences Hub Laboratory, Southampton General Hospital, Southampton, UK.
  • Tipler N; Centre for Cancer Immunology, University of Southampton, Southampton SO16 6YD, UK.
  • Menne T; Department of Haematology, Newcastle upon Tyne Hospitals National Health Service Foundation Trust, Newcastle Upon Tyne, UK.
  • Ahearne MJ; Department of Haematology, University Hospitals of Leicester National Health Service Trust, Leicester, UK; Leicester Cancer Research Centre, University of Leicester, Leicester, UK.
  • Willimott V; Department of Haematology, Norfolk and Norwich University Hospitals National Health Service Foundation Trust, Norwich, UK.
  • Al-Naeeb AB; Department of Oncology, Bedford Hospital, Bedford, UK.
  • Fox CP; School of Medicine, University of Nottingham, Nottingham University Hospitals National Health Service Trust, Nottingham, UK.
  • Collins GP; Department of Clinical Haematology, Oxford University Hospitals National Health Service Foundation Trust, Oxford, UK.
  • O'Callaghan A; Department of Oncology, Portsmouth Hospitals National Health Service Trust, Portsmouth, UK.
  • Davies AJ; Centre for Cancer Immunology, University of Southampton, Southampton SO16 6YD, UK; National Institute for Health Research and Cancer Research UK Southampton Experimental Cancer Medicine Centre, Wessex Investigational Sciences Hub Laboratory, Southampton General Hospital, Southampton, UK.
  • Goldblatt D; Great Ormond Street Institute of Child Health Biomedical Research Centre, University College London, London, UK.
  • Lim SH; Centre for Cancer Immunology, University of Southampton, Southampton SO16 6YD, UK. Electronic address: s.h.lim@soton.ac.uk.
Lancet ; 402(10396): 99-102, 2023 07 08.
Article en En | MEDLINE | ID: mdl-37393922
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: COVID-19 Tipo de estudio: Etiology_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Lancet Año: 2023 Tipo del documento: Article País de afiliación: Reino Unido
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: COVID-19 Tipo de estudio: Etiology_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Lancet Año: 2023 Tipo del documento: Article País de afiliación: Reino Unido